Short-time stability of markers of coagulation and fibrinolysis in frozen plasma

Thrombosis Research

Volumn 81, Issue 2, 1996, Pages 253-261

  Iversen, Lene H ^a   Thorlacius Ussing, Ole ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Blood coagulation factors; Blood specimen handling; Enzyme linked immunosorbent assay; Fibrin fibrinogen degradation products; Quality control; Soluble fibrin

Indexed keywords

ANTITHROMBIN III; FIBRIN DEGRADATION PRODUCT; FRESH FROZEN PLASMA; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; QUALITY CONTROL;

EID: 0029933322     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00242-1     Document Type: Article

References (17)

1. THOMPSON, S.G., MARTIN, J.C. and MEADE, T.W. Sources of variability in coagulation factor assays. Thromb Haemost 58, 1073-1077, 1987.
2. GREENBERG, C.S., HURSTING, M.J., MACIK, B.G., ORTEL, T.L, KANE, W.H. and MOORE, B.M. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem 40, 1962-1969, 1994.
3. HALVORSEN, S., SKJØNSBERG, O.H. and GODAL, H.C. Comparison of methods for detecting soluble fibrin in plasma from patients with venous thromboembolism. Thromb Res 61, 341-348, 1991.
4. WIEDING, J.U. and HOSIUS, C. Determination of soluble fibrin: a comparison of four different methods. Thromb Res 65, 745-756, 1992.
5. PAPP, A.C., HATZAKIS, H., BRACEY, A. and WU, K.K. ARIC* Hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61, 15-19, 1989.
6. IVERSEN, L.H., THORLACIUS-USSING, O. and OKHOLM, M. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thromb Res 79, 471-481, 1995.
7. PELZER, H., SCHWARZ, A. and STUBER, W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide [see comments]. Thromb Haemost 65, 153-159, 1991.
8. PELZER, H., SCHWARZ, A. and HEIMBURGER, N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59, 101-106, 1988.
9. LILL, H., SPANNAGL, M., TRAUNER, A., SCHRAMM, W., SCHULLER, D., OFENLOCH HAEHNLE, B., DRAEGER, B., NASER, W. and DESSAUER, A. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinolysis 4, 97-102, 1993.
10. KOOPMAN, J., HAVERKATE, F., KOPPERT, P., NIEUWENHUIZEN, W., BROMMER, E.J. and VAN DER WERF, W.G. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 109, 75-84, 1987.
11. ARMITAGE, P. and BERRY, G. The size of a statistical investigation. In: Statistical methods in medical research. Pp 179-85, Blackwell Scientific Publications, Oxford (1987).
12. FRASER, C.G. and HARRIS, E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27, 409-437, 1989.
13. FRASER, C.G., HYLTOFT PETERSON, P. and LARSEN, M.L. Setting analytical goals for random analytical error in specific clinical monitoring situations [see comments]. Clin Chem 36, 1625-1628, 1990.
14. FRASER, C.G. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med 116, 916-923, 1992.
15. FRASER, C.G. Data on biological variation: essential prerequisites for introducing new procedures? [editorial]. Clin Chem 40, 1671-1673, 1994.
16. THOMPSON, S.G., DUCKERT, F., HAVERKATE, F. and THOMSON, J.M. The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT). Thromb Haemost 61, 301-306, 1989.
17. NGUYEN, N.D., GHADDAR, H., STINSON, V., CHAMBLESS, L.E. and WU, K.K. ARIC* Hemostasis study-IV. Intraindividual variability and reliability of hemostatic factors. Thromb Haemost 73, 256-260, 1995.